ReviewLife (Basel, Switzerland)2022
Coronary Vasospastic Angina: A Review of the Pathogenesis, Diagnosis, and Management.
Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Effect of Statins on Major Adverse Cardiovascular Events in Patients with Coronary Artery Spasm: A Meta-Analysis of the Asia Region.Cardiovascular therapeutics · 2023Pooled it
- From exercise to emergency-an extreme presentation of MINOCA: a case report.European heart journal. Case reports · 2026Article
- Article
- Myocardial Stunning Induced by Vasospasm Within an Intercoronary Communication.JACC. Case reports · 2026Article
- Vasospastic Angina Masquerading as Plaque Erosion on Optical Coherence Tomography.JACC. Case reports · 2026Article
- Coronary artery spasm in cardiac arrest survivors.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Review
- When SVT is Not Benign: Troponin Elevation Revealing Coronary Vasospasm, A Case Report.Clinical medicine insights. Case reports · 2026Article
- Reversible cerebral vasoconstriction syndrome with concomitant recurrent subarachnoid hemorrhage and coronary vasospastic angina: A manifestation of systemic vasoconstriction syndrome.Surgical neurology international · 2026Article
- Article
- Article
- A Comprehensive Literature Review Discussing Diagnostic Challenges of Prinzmetal or Vasospastic Angina.Cureus · 2025Review
- Anti-vasospastic mast cell stabilizers: a novel therapeutic approach to anaphylaxis-induced acute coronary syndrome.Clinical and experimental vaccine research · 2025Article
- Vasospastic Angina Unmasked on Repeat Coronary Angiography in a Patient Without Typical Triggers: A Case Report.Cureus · 2025Article
- ST-segment elevation myocardial infarction with refractory cardiogenic shock due to coronary spasm: a case report.European heart journal. Case reports · 2024Article
- Do changes in intracoronary pressure aid coronary spasm diagnosis using the spasm provocation test?World journal of cardiology · 2024Article
- Profiling oxidative stress markers and cardiovascular complications in chronic kidney disease patients supplemented with vitamin E.Archives of medical sciences. Atherosclerotic diseases · 2024Article
- A Case of Aborted Sudden Cardiac Death Due to Coronary Artery Spasm.JACC. Case reports · 2023Article
- Article
- Vasospastic Angina in a Young Woman: A Case Report.Cureus · 2023Article
- Which Coronary Artery Should Be Preferred for Starting the Coronary Spasm Provocation Test?Life (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vasospastic angina (VSA) is an under-appreciated cause of chest pain. It is characterised by transient vasoconstriction of the coronary arteries and plays a significant role in the pathogenesis of stable angina and acute coronary syndromes. Complex mechanistic pathways characterised by endothelial dysfunction and smooth muscle hypercontractility lead to a broad spectrum of clinical manifestations ranging from recurrent angina to fatal arrhythmias. Invasive provocation testing using intracoronary acetylcholine or ergonovine is considered the current gold standard for diagnosis, but there is a wide variation in protocols amongst different institutions. Conventional pharmacological therapy relies on calcium channel blockers and nitrates; however, refractory VSA has limited options. This review evaluates the pathophysiology, diagnostic challenges, and management strategies for VSA. We believe global efforts to standardise diagnostic and therapeutic guidelines will improve the outcomes for affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.